Related Experiment Videos
Abnormally thin glomerular basement membrane and the Goodpasture epitope
E Pettersson1, T Törnroth, J Wieslander
1Karolinska Institute, Department of Renal Medicine, Huddinge Hospital, Sweden.
Abstract:
Using indirect immunofluorescence, cryostat sections from renal biopsy specimens of 14 adult patients showing marked diffuse thinning of the glomerular basement membrane (GBM) on ultrastructural analysis were examined for the presence of the Goodpasture (GP) epitope M2 using anti-M2 antiserum. In no case was a total absence of M2 noted. The fluorescence pattern was fine but homogeneously linear along the GBM in 12 cases, intensity varying from +-++, as compared with for the control specimen GBM. A faint, broken line of stain, intensity+, was observed in biopsy specimens of two patients, one of whom had family members with progressive hereditary nephritis, type Alport's syndrome. Clinical presentation was dominated by hematuria (10/14 patients) but also included three patients with isolated proteinuria. Two patients had nephrotic range proteinuria. Other than the GBM changes, histological findings were sparse, with either no abnormalities or only slight mesangial increase in most. One case of focal segmental sclerosis and hyalinosis was also found. The findings from this study suggest that the abnormally thin GBM does not lack the GP epitope, but it may be reduced.
Insights
Thinning of the glomerular basement membrane (GBM) in kidney biopsies does not mean the Goodpasture (GP) epitope M2 is absent. This GBM epitope may be present but in reduced amounts, even with thin GBM disease.
Area of Science:
- Nephrology
- Immunopathology
- Renal Histology
Background:
- Glomerular basement membrane (GBM) abnormalities are associated with various kidney diseases.
- The Goodpasture (GP) epitope M2 is a key component of the GBM, crucial for its structural integrity.
- Understanding the presence of GP epitope M2 in conditions with thin GBM is important for diagnosis and understanding disease mechanisms.
Purpose of the Study:
- To investigate the presence and pattern of the Goodpasture (GP) epitope M2 in renal biopsy specimens with diffusely thin glomerular basement membranes (GBM).
- To correlate GBM M2 epitope findings with clinical presentation and other histological features in patients with thin GBM disease.
Main Methods:
- Indirect immunofluorescence was used to detect the GP epitope M2 on cryostat sections of renal biopsies from 14 adult patients.
- Patients' biopsies were previously characterized by ultrastructural analysis showing marked diffuse thinning of the GBM.
- Anti-M2 antiserum was utilized for epitope detection, with fluorescence patterns and intensity quantified.
Main Results:
- The Goodpasture (GP) epitope M2 was not completely absent in any of the 14 cases with thin GBM.
- A homogeneous linear fluorescence pattern along the GBM was observed in 12 cases, with varying intensity.
- Two cases showed a faint, broken line of M2 staining, one of whom had a family history of Alport's syndrome.
Conclusions:
- Abnormally thin glomerular basement membranes (GBM) in these patients do not lack the Goodpasture (GP) epitope M2.
- The findings suggest that the GP epitope M2 may be present but reduced in conditions characterized by thin GBM.
- These results contribute to the understanding of GBM composition in thin GBM disease and its potential implications.